Cocrystal Pharma, Inc. (COCP) NASDAQ
1.38
-0.0094(-0.68%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 11.05M |
| Enterprise Value | 5.53M |
| P/E Ratio | -1.78 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.48 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.99 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.91 |
| Return On Equity | -1.33 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -376,000 |
| EBITDA | -8.64M |
| Net Income | -8.83M |
| Diluted EPS | -0.78 |
Balance Sheet
| Total Cash | 7.03M |
| Total Cash/Share | 0.62 |
| Total Debt | 1.51M |
| Total Debt/Equity | 0.24 |
| Current Ratio | 3.68 |
| Book Value Per Share | 0.56 |
Price History
| 52-Week Change | -13.66 |
| 52-Week High | 2.67 |
| 52-Week Low | 0.86 |
| Moving Average 50 Days | 1.19 |
| Moving Average 200 Days | 1.22 |
Statistics
| Average Volume | 2.46M |
| Shares Outstanding | 10.25M |
| % Held by Institutions | 7.01 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | October 11, 2022 |
